Czito, B. G., Mulcahy, M. F., Schelman, W. R., Vaghefi, H., Jameson, G. S., Deluca, A., … Michael, M. (2014). The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study. In Journal of Clinical Oncology (Vol. 32, pp. 3634–3634). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.3634

Czito, Brian G., Mary Frances Mulcahy, William R. Schelman, Houman Vaghefi, Gayle S. Jameson, Angela Deluca, Hao Xiong, et al. “The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study.” In Journal of Clinical Oncology, 32:3634–3634. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.3634.

Czito BG, Mulcahy MF, Schelman WR, Vaghefi H, Jameson GS, Deluca A, et al. The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3634–3634.

Czito, Brian G., et al. “The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 3634–3634. Crossref, doi:10.1200/jco.2014.32.15_suppl.3634.

Czito BG, Mulcahy MF, Schelman WR, Vaghefi H, Jameson GS, Deluca A, Xiong H, Munasinghe W, Dudley MW, Holen KD, Michael M. The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3634–3634.